Rob Menendez actually said...

"the intellectual property questions in the biopharmaceutical field are incredibly important."

"For those who like it and for those who do not like it, it is the law of the land."

"I think it is time, maybe, to dust off what is called Section 301."

"I think we need to do everything we can to increase exports."